These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 32983144)

  • 61. Allogeneic hematopoietic chimerism in mice treated with sublethal myeloablation and anti-CD154 antibody: absence of graft-versus-host disease, induction of skin allograft tolerance, and prevention of recurrent autoimmunity in islet-allografted NOD/Lt mice.
    Seung E; Iwakoshi N; Woda BA; Markees TG; Mordes JP; Rossini AA; Greiner DL
    Blood; 2000 Mar; 95(6):2175-82. PubMed ID: 10706892
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Hematopoietic stem cell transplantation using single UM171-expanded cord blood: a single-arm, phase 1-2 safety and feasibility study.
    Cohen S; Roy J; Lachance S; Delisle JS; Marinier A; Busque L; Roy DC; Barabé F; Ahmad I; Bambace N; Bernard L; Kiss T; Bouchard P; Caudrelier P; Landais S; Larochelle F; Chagraoui J; Lehnertz B; Corneau S; Tomellini E; van Kampen JJA; Cornelissen JJ; Dumont-Lagacé M; Tanguay M; Li Q; Lemieux S; Zandstra PW; Sauvageau G
    Lancet Haematol; 2020 Feb; 7(2):e134-e145. PubMed ID: 31704264
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Adoptive allogeneic immunotherapy--history and future perspectives.
    Schleuning M
    Transfus Sci; 2000 Oct; 23(2):133-50. PubMed ID: 11035275
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Central and peripheral nervous system immune-mediated demyelinating disease after allogeneic hematopoietic stem cell transplantation.
    Stefanou MI; Bischof F
    J Neuroimmunol; 2017 Jun; 307():74-81. PubMed ID: 28495143
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Outcome of allogeneic Hematopoietic Stem Cell Transplantation on Diamond-Blackfan anemia using busulfan-based myeloablative regimen.
    Behfar M; Koochakzadeh L; Yazdanian N; Salajegheh P; Rostami T; Khodayari-Namini N; Ghavamzadeh A; Hamidieh AA
    Turk J Pediatr; 2019; 61(3):407-412. PubMed ID: 31916719
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Immunobiology of allogeneic hematopoietic stem cell transplantation.
    Welniak LA; Blazar BR; Murphy WJ
    Annu Rev Immunol; 2007; 25():139-70. PubMed ID: 17129175
    [TBL] [Abstract][Full Text] [Related]  

  • 67. HLA discrepancy between graft and host rather than that graft and first donor impact the second transplant outcome.
    Maeda Y; Ugai T; Kondo E; Ikegame K; Murata M; Uchida N; Miyamoto T; Takahashi S; Ohashi K; Nakamae H; Fukuda T; Onizuka M; Eto T; Ota S; Hirokawa M; Ichinohe T; Atsuta Y; Kanda Y; Kanda J;
    Haematologica; 2019 May; 104(5):1055-1061. PubMed ID: 30523056
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study.
    Sun Y; Meng F; Han M; Zhang X; Yu L; Huang H; Wu D; Ren H; Wang C; Shen Z; Ji Y; Huang X
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1117-26. PubMed ID: 25840339
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The role of purine analogues in low-intensity regimens with allogeneic hematopoietic stem cell transplantation.
    Foss FM
    Semin Hematol; 2006 Apr; 43(2 Suppl 2):S35-43. PubMed ID: 16549113
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases.
    Slavin S; Nagler A; Naparstek E; Kapelushnik Y; Aker M; Cividalli G; Varadi G; Kirschbaum M; Ackerstein A; Samuel S; Amar A; Brautbar C; Ben-Tal O; Eldor A; Or R
    Blood; 1998 Feb; 91(3):756-63. PubMed ID: 9446633
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Altered homeostasis of CD4(+) memory T cells in allogeneic hematopoietic stem cell transplant recipients: chronic graft-versus-host disease enhances T cell differentiation and exhausts central memory T cell pool.
    Fukunaga A; Ishikawa T; Kishihata M; Shindo T; Hori T; Uchiyama T
    Biol Blood Marrow Transplant; 2007 Oct; 13(10):1176-84. PubMed ID: 17889354
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Lymphocyte reconstitution following allogeneic hematopoietic stem cell transplantation: a retrospective study including 148 patients.
    Heining C; Spyridonidis A; Bernhardt E; Schulte-Mönting J; Behringer D; Grüllich C; Jakob A; Bertz H; Finke J
    Bone Marrow Transplant; 2007 May; 39(10):613-22. PubMed ID: 17384658
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Multicenter analyses demonstrate significant clinical effects of minor histocompatibility antigens on GvHD and GvL after HLA-matched related and unrelated hematopoietic stem cell transplantation.
    Spierings E; Kim YH; Hendriks M; Borst E; Sergeant R; Canossi A; Oudshoorn M; Loiseau P; Dolstra H; Markiewicz M; Leffell MS; Pereira N; Kircher B; Turpeinen H; Eliaou JF; Gervais T; Laurin D; Enczmann J; Martinetti M; Thomson J; Oguz F; Santarone S; Partanen J; Siekiera U; Alessandrino EP; Kalayoglu S; Brand R; Goulmy E
    Biol Blood Marrow Transplant; 2013 Aug; 19(8):1244-53. PubMed ID: 23756210
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cytotoxic Pathways in Allogeneic Hematopoietic Cell Transplantation.
    Du W; Cao X
    Front Immunol; 2018; 9():2979. PubMed ID: 30631325
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Allogeneic donor split skin grafts for treatment of refractory ulcers in cutaneous chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation-a retrospective analysis on seven patients.
    Lamby P; Wolff D; Mielke S; Grigoleit GU; Ljungman P; Hilgendorf I; Holler E; Holler B; Weber D; Herr W; Schiltz D; Klein S; Graf S; Bjornhagen-Safwenberg V; Dolderer J; Prantl L
    Ann Hematol; 2019 Aug; 98(8):1867-1875. PubMed ID: 30993415
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The enteric toxicity of gluten enhances graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Neuman T; David K; Cooper D; Strair R
    Med Hypotheses; 2017 Jul; 104():174-177. PubMed ID: 28673580
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Successful Hematopoietic Stem Cell Transplantation in a Patient with LPS-Responsive Beige-Like Anchor (LRBA) Gene Mutation.
    Tesi B; Priftakis P; Lindgren F; Chiang SC; Kartalis N; Löfstedt A; Lörinc E; Henter JI; Winiarski J; Bryceson YT; Meeths M
    J Clin Immunol; 2016 Jul; 36(5):480-9. PubMed ID: 27146671
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Allogeneic cell therapy for patients who relapse after autologous stem cell transplantation.
    Porter DL; Luger SM; Duffy KM; Stadtmauer EA; Laport G; Schuster SJ; Orloff G; Tsai D; McDaid K; Kathakali A; Leonard DG; Antin JH
    Biol Blood Marrow Transplant; 2001; 7(4):230-8. PubMed ID: 11349810
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pathogenesis, risk factors and therapeutic options for autoimmune haemolytic anaemia in the post-transplant setting.
    Gabelli M; Ademokun C; Cooper N; Amrolia PI
    Br J Haematol; 2022 Jan; 196(1):45-62. PubMed ID: 34195990
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Metabolic Potential of the Gut Microbiome Is Significantly Impacted by Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation Recipients.
    Jørgensen M; Nørgaard JC; Ilett EE; Marandi RZ; Noguera-Julian M; Paredes R; Murray DD; Lundgren J; MacPherson CR; Sengeløv H
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.